Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The liminal self in people with multiple sclerosis: An interpretative phenomenological exploration of being diagnosed.
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histology.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Navarra, Gipuzkoa and La Rioja].
Ibudilast for the treatment of multiple sclerosis.
SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.
Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
Poster 11 A Rare Case of Chronic Inflammatory Demyelinating Polyneuropathy in the Setting of SLE: A Case Report.
Effect of Lipopolysaccharide Derived from Pantoea agglomerans on the Phagocytic Activity of Amyloid β by Primary Murine Microglial Cells.
Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice.
Overview and diagnosis of multiple sclerosis.
microRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer's Disease (AD).
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors.
Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon.
Assisted suicide and the law.
Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses.
Therapeutic application of monoclonal antibodies in multiple sclerosis.
Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease.
Statins: a revised appraisal for potential additional future treatment indications.
Progressive multifocal leukoencephalopathy.
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
Nogo-A does not inhibit retinal axon regeneration in the lizard, Gallotia galloti.
"Gait responder" to fampridine, a too restrictive concept?
[Cannabis: Effects in the Central Nervous System. Therapeutic, societal and legal consequences].
A Novel Pathophysiological Mechanism Contributing to Trigeminal Neuralgia.

Pages